Riskpilot← Back to searchSign inGet full accessBUXCONSULTING AS
ASActiveOrg 922328749Sandakerveien 78, 0484 OsloGeneral medical practice activities · NACE 8621Est. 20192 employees
Revenue 2024
NOK 3,6M
-9% vs 2023
EBITDA margin
28.4%
-4% vs 2023
Equity ratio
85.2%
Financial strength
Net profit 2024
NOK 678K
-6% vs 2023
| Revenue | NOK 3,6M | -9% |
| EBITDA | NOK 1M | -4% |
| Net profit | NOK 678K | -6% |
| Total assets | NOK 5,6M | +1% |
| Equity | NOK 4,8M | +16% |
| Employees | 2 | — |
Legal name
BUXCONSULTING AS
Org number
922328749
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
4. mars 2019
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Lege og konsulentvirksomhet innen helse og omsorg. Dessuten eie fast eiendom, eiendomsutvikling og utleie av fast eiendom, eie aksjer i andre selskap, investere i aksjer og andre verdipapirer, samt annen virksomhet som står i naturlig tilknytning til dette.
Address
Sandakerveien 78, 0484 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 190 | 3 667 | 4 024 | 3 969 | 3 602 |
| Staff expenses | −9 | −251 | −1 502 | −977 | −1 010 |
| EBITDA | 1 903 | 2 563 | 1 312 | 1 063 | 1 021 |
| Depreciation & amort. | −0 | −0 | −152 | −152 | −152 |
| EBIT | 1 903 | 2 563 | 1 160 | 911 | 870 |
| Net financials | −1 | 0 | −0 | 3 | 2 |
| Profit before tax | 1 902 | 2 563 | 1 160 | 914 | 871 |
| Tax | 418 | 564 | 255 | 193 | 194 |
| Net profit | 1 483 | 1 999 | 904 | 721 | 678 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 329 | 4 795 | 5 766 | 5 605 | 5 648 |
| Equity | 1 327 | 2 878 | 3 689 | 4 134 | 4 812 |
| Long-term debt | 0 | 0 | 1 135 | 753 | 53 |
| Short-term debt | 1 002 | 1 917 | 941 | 718 | 784 |
| Total debt | 1 002 | 1 917 | 2 076 | 1 471 | 837 |
EBITDA margin
28.4%
This company
15.8%
Market median
+80% vs market
20202024
Equity ratio
85.2%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
14.1%
This company
18.4%
Market median
+23% vs market
20202024
Net profit margin
18.8%
This company
8.1%
Market median
+132% vs market
20202024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20202024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bux Holding As
BUXCONSULTING AS Board members of BUXCONSULTING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Luqman Tasadduq Chaudhari | Chairman | 0 companies |